Skip to main content

Table 2 Cancer cases diagnosed in the study population

From: Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan

Sr. No Cancer ICD-10 Male (n = 2436) Female (n = 1964) Total (n = 4400)
n (%) n (%) n (%)
1 Bladder C67 42 (1.7) 32 (1.6) 74 (1.7)
2 Brain C70–72 111 (4.6) 70 (3.6) 181 (4.1)
3 Breast C50 378 (19.2) 378 (8.6)
4 Cervix uteri C53 142 (7.2) 142 (3.2)
5 Colorectal C18–21 131 (5.4) 43 (2.2) 174 (4.0)
6 Corpus uteri C54 71 (3.6) 71 (1.6)
7 Gallbladder C23–24 110 (4.5) 71 (3.6) 181 (4.1)
8 Hodgkin lymphoma C81 149 (6.1) 43 (2.2) 192 (4.4)
9 Kidney C64–66 178 (7.3) 114 (5.8) 292 (6.6)
10 Larynx C32 111 (4.6) 70 (3.6) 181 (4.1)
11 Leukemia C91–95 221 (9.1) 113 (5.8) 334 (7.6)
12 Lip, oral cavity C00–08 110 (4.5) 70 (3.6) 180 (4.1)
13 Liver C22 111 (4.6) 70 (3.6) 181 (4.1)
14 Lung C33–34 186 (7.6) 104 (5.3) 290 (6.6)
15 Non-Hodgkin lymphoma C82–85 363 (14.9) 177 (9.0) 540 (12.3)
16 Esophagus C15 107 (4.4) 71 (3.6) 178 (4.0)
17 Ovary C56 141 (7.2) 141 (3.2)
18 Pancreas C25 111 (4.6) 70 (3.6) 181 (4.1)
19 Prostate C61 220 (9.0) 220 (5.0)
20 Stomach C16 65 (2.7) 43 (2.2) 108 (2.5)
21 Thyroid C73 110 (4.5) 71 (3.6) 181 (4.1)